Laboratory of Pathophysiology and Experimental Therapy, E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk, Russia.
Bull Exp Biol Med. 2022 Aug;173(4):419-423. doi: 10.1007/s10517-022-05560-w. Epub 2022 Sep 5.
We studied the role of JAKs and STAT3 in the growth potential of neural stem cells and the humoral neurotrophic function of neuroglia in modeling β-amyloid-induced neurodegeneration in vitro. It was found that these signaling molecules do not participate in the neural stem cell functioning, and JAKs plays an inhibitory role (realized, however, without STAT3) in the secretion of neurotrophins by glial cells under conditions of their optimal vital activity. The effect of β-amyloid on progenitor cells is accompanied by the appearance of a "negative" effect of STAT3 signaling pathway on their proliferative activity. At the same time, JAKs and STAT3 during neurodegeneration stimulate specialization/differentiation of neural stem cells and production of growth factors by neuroglial cells. These results indicate the possibility of stimulating proliferation of neural stem cells coupled with their differentiation by using selective STAT3 inhibitors.
我们研究了 JAK 和 STAT3 在神经干细胞生长潜力和神经胶质细胞体液神经营养功能中的作用,以建立体外β-淀粉样蛋白诱导的神经退行性变模型。结果发现,这些信号分子不参与神经干细胞的功能,并且 JAK 在神经胶质细胞最佳存活活性条件下,通过 STAT3 发挥神经营养因子分泌的抑制作用(然而,这种作用是没有 STAT3 实现的)。β-淀粉样蛋白对祖细胞的作用伴随着 STAT3 信号通路对其增殖活性的“负”作用的出现。同时,JAK 和 STAT3 在神经退行性变过程中刺激神经干细胞的特化/分化以及神经胶质细胞生长因子的产生。这些结果表明,通过使用选择性 STAT3 抑制剂,有可能刺激神经干细胞的增殖并与其分化相结合。